(Q35808440)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Pharmacogenetics and proteomics of anticancer drugs in non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Pier Luigi Zinzani

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Romano Danesi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Lucia Loni

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

44 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

S115-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15202534%20AND%20SRC:MED&resulttype=core&format=json

Changing incidence of non-Hodgkin lymphomas in the United States

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623676

Nucleoside analogues and nucleobases in cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623676

Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623676

Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623676

Pleiotropic drug resistance in B-cell chronic lymphocytic leukaemia--the role of Bcl-2 family dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623676

Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001623676

10.1080/10428190310001623676

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/edhgs72gzfh6rlpjgzpq2ci6ca

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_edhgs72gzfh6rlpjgzpq2ci6ca

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/edhgs72gzfh6rlpjgzpq2ci6ca

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/edhgs72gzfh6rlpjgzpq2ci6ca

1 reference